SPY749.60−0.63%QQQ674.25−0.83%BTC/USD66,760.83−2.16%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

National Health Investors Inc

NHINYSE

Trade with Public

$62.95

-1.60-2.48%

At close: Nov 13, 4:00 PM EST

$62.95

N/A

After Hours: 6:01 PM EST

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Mon Nov 9th, after the market close

Conference Call: The most recent conference call started at 10:00 AM, 3 days ago

Click to view the webcast

National Health Investors (NHI) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for National Health Investors (NHI) stock.

Analyst Consensus — 8 Analysts

6Buy

2Hold

# Analysts8

Latest Upgrades and Downgrades for National Health Investors Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	B of A Securities	Joshua Dennerlein	Downgrade	Buy→Underperform	$86→$67
—	Wells Fargo	James Feldman	PT Cut	Equal-Weight	$78→$68
—	Truist Securities	Michael Lewis	PT Cut	Buy	$81→$80
—	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$79→$78
—	Deutsche Bank	Omotayo Okusanya	PT Cut	Hold	$85→$80
—	BMO Capital	Juan Sanabria	PT Cut	Outperform	$90→$80
—	Truist Securities	Michael Lewis	PT Cut	Buy	$89→$81
—	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$84→$79
—	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$86→$84
—	Cantor Fitzgerald	Richard Anderson	Maintained	Overweight	$94
—	Truist Securities	Michael Lewis	PT Cut	Buy	$92→$89
—	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$85→$86
—	Truist Securities	Michael Lewis	PT Raise	Buy	$85→$92
—	Truist Securities	Michael Lewis	PT Raise	Buy	$81→$83
—	Keybanc	Todd M. Thomas	PT Raise	Overweight	$80→$88
—	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$80→$85
—	Cantor Fitzgerald	Richard Anderson	Initiate	Overweight	$90
—	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$76→$80
—	Truist Securities	Michael Lewis	PT Raise	Buy	$77→$81
—	Keybanc	Craig Mailman	Upgrade	Sector Weight→Overweight	$80

National Health Investors Inc

National Health Investors (NHI) Stock Price Target 2026

Latest Upgrades and Downgrades for National Health Investors Stock

National Health Investors (NHI) Stock Price Target 2026

Latest Upgrades and Downgrades for National Health Investors Stock

Analyst Ratings News

PRO
B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

People Also Watch

People Also Watch

Analyst Ratings News

PRO
B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

National Health Investors Inc

National Health Investors (NHI) Stock Price Target 2026

Latest Upgrades and Downgrades for National Health Investors Stock

National Health Investors (NHI) Stock Price Target 2026

Latest Upgrades and Downgrades for National Health Investors Stock

Analyst Ratings News

PROB of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68

PROTruist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRODeutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PROBMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

People Also Watch

People Also Watch

Analyst Ratings News

PROB of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68

PROTruist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRODeutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PROBMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PRO
B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PRO
B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80